StemCells, Inc. (NASDAQ:STEM) announced that management will present at the 4(th) LD Micro Invitational Conference, on Wednesday, June 4, at 11:30 AM PDT. StemCells Inc. (NASDAQ:STEM) weekly performance is 9.02%. On last trading day company shares ended up $1.45. Analysts mean target price for the company is $3.19. StemCells Inc. (NASDAQ:STEM) distance from 50-day simple moving average (SMA50) is 10.60%.
During early morning yesterday, 22nd Century Group Inc. (NYSEMKT:XXII) announced that its wholly-owned holding company, Goodrich Tobacco Company LLC, has entered into an agreement with Poland based Orion, which is also a cigarette manufacturer. The letter of intent exchanged between the two companies is with respect to 22nd Century’s plan to give Orion, a contract to manufacture and distribute its patented tobacco products across the European continent. 22nd Century Group Inc. (NYSEMKT:XXII) shares advanced 2.55% in last trading session and ended the day on $2.82. XXII return on assets is -468.20%.22nd Century Group Inc. (NYSEMKT:XXII) quarterly performance is -37.19%.
xG Technology Inc. (NASDAQ:XGTI) announced Thursday morning that it has been awarded a new patent for interference mitigation techniques. This is the second new patent the company has been granted this week. XG Technology Inc. (NASDAQ:XGTI) shares moved up 23.53% in last trading session and was closed at $2.10, while trading in range of $2.10 – $2.94. XG Technology Inc. (NASDAQ:XGTI) year to date (YTD) performance is 32.91%.
NeoStem Inc. (NASDAQ:NBS) does a retrospective pooled analysis of three melanoma clinical trials conducted from 1990 – 2011 and concludes that its Melapuldencel-T autologous immunotherapy may increase Overall Survival (OS) in patients with metastatic melanoma. Carefully parsing the data, the company finds that OS in the Melapuldencel-T cohort was 33% compared to 20% in patients treated with irradiated autologous tumor cells for the subset of patients who still had evidence of disease after prior treatment with one or more standard therapies. NeoStem Inc. (NASDAQ:NBS) ended the last trading day at $6.81. Company weekly volatility is calculated as 6.13% and price to cash ratio as 5.02.NeoStem Inc. (NASDAQ:NBS) showed a positive weekly performance of 14.65%.
German telecom giant Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) is willing to hold onto a portion of T-Mobile US (NYSE:TMUS) in its deal to sell the U.S. phone service to Japan’s Softbank, Reuters reported, citing sources close to the situation. On last trading day company shares ended up $16.58.